| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6120820 | Journal of Clinical Virology | 2014 | 8 Pages |
Abstract
HCV RNA profiles with telaprevir/Peg-IFN/RBV are different from those with Peg-IFN/RBV alone. It is important that clinicians understand these HCV RNA profiles and monitor patient viral load in order to apply futility rules correctly.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Gaston Picchio, Sandra De Meyer, Inge Dierynck, Anne Ghys, Linda Gritz, Tara L. Kieffer, Douglas J. Bartels, Jim Witek, Leif Bengtsson, Donghan Luo, Robert S. Kauffman, Nathalie Adda, Christoph Sarrazin,